Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

SHA:603811 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	166.37	220.7	173.04	294.14	213.51	83.32
Cash & Short-Term Investments	166.37	220.7	173.04	294.14	213.51	83.32
Cash Growth	-16.26%	27.55%	-41.17%	37.77%	156.25%	15.23%
Accounts Receivable	51.22	38.96	72.91	93.18	90.44	78.79
Other Receivables	14.18	1.56	6.47	2.87	1.28	1.33
Receivables	65.39	40.52	79.38	96.05	91.72	80.12
Inventory	110.06	116.34	131.84	116.78	111.04	117
Other Current Assets	105.6	17.92	9.36	10.45	20.57	7.35
Total Current Assets	447.42	395.49	393.62	517.42	436.84	287.8
Property, Plant & Equipment	880.2	891.23	945.69	1,003	919.65	668.66
Long-Term Investments	335.18	336.72	314.87	281.13	234.01	208.2
Goodwill	-	-	-	-	-	2.42
Other Intangible Assets	52.13	53.02	63.95	66.66	68.45	70.19
Long-Term Deferred Tax Assets	10.66	8	6.3	5.94	17.47	5.16
Long-Term Deferred Charges	0.25	0.2	0.41	1.43	1.44	2.24
Other Long-Term Assets	25.43	17.7	3.55	17.55	41.24	77.83
Total Assets	1,751	1,702	1,728	1,893	1,719	1,322

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	48.86	53.69	84.67	118.91	54.79	57.5
Accrued Expenses	10.67	131.87	78.28	76.15	79.75	72.57
Short-Term Debt	24.91	15.01	51.1	117.33	76.5	86.36
Current Portion of Long-Term Debt	-	17.04	40.43	8.91	14.02	-
Current Portion of Leases	-	-	0.02	0.75	0.61	0.76
Current Income Taxes Payable	25.11	13.87	6.4	-	-	7.83
Current Unearned Revenue	21.52	7.59	12.22	4.38	13.74	6.11
Other Current Liabilities	135.63	27.25	18.38	16.22	18.59	15.75
Total Current Liabilities	266.7	266.33	291.5	342.65	257.99	246.87
Long-Term Debt	25	5.7	139.31	316.38	334.77	59.63
Long-Term Leases	-	-	-	0.47	0.91	1.79
Long-Term Unearned Revenue	20.83	20.42	18.77	21.29	16.93	12.22
Long-Term Deferred Tax Liabilities	11.29	12.1	13.74	15.37	17.56	3.11
Total Liabilities	323.81	304.55	463.31	696.15	628.16	323.62

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	458.23	327.3	327.3	327.3	233.79	233.79
Additional Paid-In Capital	39.89	138.71	143	143	236.51	238.08
Retained Earnings	969.42	972.74	857.04	721.8	617.36	514.22
Treasury Stock	-48.29	-48.29	-67.26	-	-	-
Comprehensive Income & Other	-	-	-	0.21	0.23	0.22
Total Common Equity	1,419	1,390	1,260	1,192	1,088	986.31
Minority Interest	8.21	7.33	4.98	4.3	3.05	12.57
Shareholders' Equity	1,427	1,398	1,265	1,197	1,091	998.88
Total Liabilities & Equity	1,751	1,702	1,728	1,893	1,719	1,322

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	49.91	37.75	230.86	443.84	426.8	148.54
Net Cash (Debt)	116.46	182.95	-57.82	-149.7	-213.3	-65.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.26	0.41	-0.13	-0.33	-0.46	-0.14
Filing Date Shares Outstanding	460.61	444.76	446.45	458.23	458.23	458.23
Total Common Shares Outstanding	460.61	444.76	446.45	458.23	458.23	458.23
Working Capital	180.72	129.16	102.12	174.78	178.85	40.93
Book Value Per Share	3.08	3.13	2.82	2.60	2.37	2.15
Tangible Book Value	1,367	1,337	1,196	1,126	1,019	913.7
Tangible Book Value Per Share	2.97	3.01	2.68	2.46	2.22	1.99
Buildings	-	656.16	656.07	686.92	441.63	374.71
Machinery	-	681.75	672.02	687.58	600.01	443.66
Construction In Progress	-	30.71	5.15	6.16	182.6	99.91

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error